Nifty - Sector wise comparison | Select your trades wiselyThanks for coming to this update.
Before you start reading kindly hit that like button. It motivates me to keep doing such work for free.
Thanks
The chart above shows Nifty's sector-wise analysis.
As we can see, the Pharma sector has performed the best in terms of returns since the crash followed by the IT sector.
Finance and Realty (Real estate) have performed the worst with almost the same level of % gain.
A few things to notice would be that the Pharma sector has been moving sideways for almost a month and the IT sector is now the sector that is going up.
Finance and Realty have gone down and may show some bounce from where they are, but may not be good enough to start going long unless you have a long term perspective in mind.
The rest of the sectors have been fairly sideways with occasional bounces and dips.
Having knowledge of the sector performance while investing, holding positions, or even Intraday is beneficial and thus plan your trades accordingly.
Please note: These are my views and not trading advice. Please consult your financial adviser before making any trading decision.
“Trading doesn't just reveal your character, it also builds it if you stay in the game long enough.”
Niftypharma
DR REDDY , 1 Day Analysis , Inside Bar Overall Strong Uptrend Move .
Previous 6 Days Price Stucked In A Range Formed Inside Bar 5 Candle Close In It .
ADX Above 25
+DI Above -DI
Buy Above :- 4080 (Aggressive) , 4128 (Conventional )
Sl :- 3950
Target :- 4310-4390
Trail Your Sl And Try to Ride the Big Rally .
Happy Trading .
Nifty Pharma's Outperformance On PauseIn November the Nifty Pharma / Nifty 100 ratio met our downside objective as momentum diverged positively, sparking a massive 6-month period of outperformance from the Pharma sector. We've ridden this trend since it started, but prices are now back at the ratios 2014 lows and beginning to fail. What acted as support is now resistance...and following the massive run prices have had, this is a very logical level for prices to pull back and digest their recent gains. As long as prices are below their recent highs, then we'd expect the Pharma sector to underperform in the near-term. Long-term the trend in this ratio is clearly higher, but for now, we want to be taking profits as money rotates into other areas of the market that haven't run as much...like Nifty Financial Services. You can view our other ideas discussing this topic linked below.
Nifty Pharma Meets Near-Term ResistanceAfter a 55% rally off its March lows, the Nifty Pharma Index has confirmed a failed breakout by closing back below resistance at its early 2019 highs of 9,500. As long as prices are below that level then we'd expect some near-term weakness in this hot sector. There's a large level of support down below near 8,350, so as long as prices are above that level then any pullback would be viewed as constructive digestion of the recent gainst. We're seeing a rotation out of areas like Pharma that have led the recent rally and into laggards like Financial Services which will push the major indices higher in the near-term. Overall, the Pharma sector remains one of the strongest areas of the market, but our expectation is for some profit-taking in the coming days and weeks.
A potential long on Aurobindo Pharma!A long trade can be initiated around 675 levels, if Aurobindo Pharma sustains above it's resistance zone above 650, with targets close to 800 and a stop loss around 615. The Risk to reward is high, with the trade having high probabilities of success, if 675 is tested and our entry price is hit.